Authors: Colls, BM

Citation: Bm. Colls, Tumour markers in malignancies - CA19.9 is useful in several cancers ... as are monoclonal immunoglobulin and beta human chorionic gonadotrophin, BR MED J, 321(7257), 2000, pp. 380-380

Authors: Hanley, JP MacLean, FR Evans, JL Colls, BM Robinson, BA Patton, WN Heaton, DC

Citation: Jp. Hanley et al., Hemorrhagic lymphadenopathy as a presenting feature of primary AL amyloidosis, PATHOLOGY, 32(1), 2000, pp. 21-23

Authors: Colls, BM Harvey, VJ Skelton, L Frampton, CMA Thompson, PI Bennett, M Perez, DJ Dady, PJ Forgeson, GV Kennedy, ICS

Citation: Bm. Colls et al., Late results of surveillance of clinical stage I nonseminoma germ cell testicular tumours: 17 years' experience in a national study in New Zealand, BJU INT, 83(1), 1999, pp. 76-82

Authors: Colls, BM

Citation: Bm. Colls, A salutary lesson - Three very unwise men, BR MED J, 318(7200), 1999, pp. 1729-1729

Authors: Colls, BM

Citation: Bm. Colls, Clinical stage I testis cancer: Long-term outcome of patients on surveillance, J UROL, 162(1), 1999, pp. 169-169

Authors: Colls, BM

Citation: Bm. Colls, Monoclonal gammopathy of undetermined significance (MGUS) - 31 year followup of a community study, AUST NZ J M, 29(4), 1999, pp. 500-504